Operating Expenses

Cost Of Sales, Operating Expenses, And Other-net

Eli Lilly Cost Of Sales, Operating Expenses, And Other-net decreased by 0.7% to $10.95B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.1%, from $9.27B to $10.95B. Over 4 years (FY 2021 to FY 2025), Cost Of Sales, Operating Expenses, And Other-net shows an upward trend with a 15.5% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
Metric ID: operating_expenses_cost_of_sales_operating_expenses_and__447d43

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$5.15B$5.53B$6.16B$5.76B$5.40B$5.38B$5.21B$5.43B$6.22B$9.07B$6.85B$6.23B$7.79B$9.85B$8.49B$9.27B$8.78B$10.37B$11.03B$10.95B
QoQ Change—+7.4%+11.4%-6.6%-6.2%-0.4%-3.2%+4.3%+14.6%+45.8%-24.5%-9.0%+24.9%+26.5%-13.8%+9.2%-5.3%+18.1%+6.3%-0.7%
YoY Change————+4.9%-2.7%-15.5%-5.7%+15.3%+68.7%+31.5%+14.8%+25.1%+8.6%+24.1%+48.8%+12.8%+5.3%+29.8%+18.1%
Range$5.15B – $11.03B
CAGR+17.2%
Avg YoY Growth+17.7%
Median YoY Growth+15.0%

Frequently Asked Questions

What is Eli Lilly's cost of sales, operating expenses, and other-net?
Eli Lilly (LLY) reported cost of sales, operating expenses, and other-net of $10.95B in Q1 2026.
How has Eli Lilly's cost of sales, operating expenses, and other-net changed year-over-year?
Eli Lilly's cost of sales, operating expenses, and other-net increased by 18.1% year-over-year, from $9.27B to $10.95B.
What is the long-term trend for Eli Lilly's cost of sales, operating expenses, and other-net?
Over 4 years (2021 to 2025), Eli Lilly's cost of sales, operating expenses, and other-net has grown at a 15.5% compound annual growth rate (CAGR), from $22.16B to $39.45B.